Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 222.82M | 216.93M | 180.84M | 142.91M | 104.24M | 62.92M |
Gross Profit | 180.06M | 175.64M | 146.34M | 114.73M | 83.46M | 51.38M |
EBITDA | 24.83M | 27.28M | 8.28M | -15.71M | -10.92M | -6.04M |
Net Income | 23.04M | 26.74M | 2.84M | 7.02M | -13.60M | -7.65M |
Balance Sheet | ||||||
Total Assets | 197.67M | 190.71M | 158.38M | 283.67M | 268.22M | 254.61M |
Cash, Cash Equivalents and Short-Term Investments | 91.90M | 92.58M | 72.03M | 216.47M | 215.32M | 219.66M |
Total Debt | 1.12M | 1.50M | 2.11M | 3.07M | 4.00M | 3.82M |
Total Liabilities | 145.24M | 132.95M | 107.65M | 91.46M | 77.57M | 53.94M |
Stockholders Equity | 52.43M | 57.76M | 50.72M | 192.21M | 190.66M | 200.67M |
Cash Flow | ||||||
Free Cash Flow | 27.43M | 28.00M | 15.33M | 1.21M | -4.40M | 3.71M |
Operating Cash Flow | 28.77M | 29.25M | 15.96M | 2.29M | -3.25M | 5.16M |
Investing Cash Flow | -1.59M | -1.50M | -9.52M | -2.15M | -1.15M | -3.90M |
Financing Cash Flow | -16.16M | -6.84M | -151.00M | 1.58M | 422.00K | 172.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $1.29B | 44.03 | 55.53% | ― | 18.51% | 32.49% | |
50 Neutral | C$3.52B | 0.80 | -5.03% | 7.64% | 16.88% | -2.22% | |
― | $7.50B | 17.84 | 10.73% | 3.40% | ― | ― | |
― | $8.53B | 59.98 | 10.66% | ― | ― | ― | |
73 Outperform | C$5.59B | 162.79 | 5.93% | ― | 15.81% | 22.17% | |
60 Neutral | C$138.10M | 148.18 | 1.61% | ― | 16.12% | ― | |
53 Neutral | C$2.25B | ― | -36.64% | ― | 18.75% | -386.84% |
Docebo reported strong financial results for the second quarter of 2025, surpassing revenue and profitability expectations despite a challenging macroeconomic environment. The company achieved significant milestones, such as advancing its AI-first strategy, appointing a new Chief Revenue Officer, and obtaining FedRAMP Moderate Authorization to expand its public sector reach. These developments, along with notable customer wins across various industries, position Docebo for sustained growth and enhanced market presence.
The most recent analyst rating on (TSE:DCBO) stock is a Buy with a C$54.00 price target. To see the full list of analyst forecasts on Docebo stock, see the TSE:DCBO Stock Forecast page.
Docebo Inc. announced the results of its annual general meeting of shareholders, where all seven nominees for the board of directors were elected. Additionally, the appointment of KPMG LLP as auditors for the 2025 fiscal year was approved. These outcomes reinforce Docebo’s governance structure and operational stability, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (TSE:DCBO) stock is a Buy with a C$54.00 price target. To see the full list of analyst forecasts on Docebo stock, see the TSE:DCBO Stock Forecast page.
Docebo Inc. announced the results of its annual general meeting of shareholders, where all seven nominees for the board of directors were elected. Additionally, the appointment of KPMG LLP as the company’s auditors for the 2025 fiscal year was approved. These outcomes reflect strong shareholder support and are expected to reinforce Docebo’s strategic direction and operational stability.
The most recent analyst rating on (TSE:DCBO) stock is a Buy with a C$54.00 price target. To see the full list of analyst forecasts on Docebo stock, see the TSE:DCBO Stock Forecast page.